Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL PD 1 W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL PD 1 W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that serves as a caloric agent and increases osmotic pressure to facilitate ultrafiltration during peritoneal dialysis. The osmotic gradient created by dextrose drives the removal of waste products and excess fluid from the blood across the peritoneal membrane.
Dianeal PD-2 with Dextrose 1.5% is a peritoneal dialysis solution. Dextrose acts as an osmotic agent to create an osmotic gradient across the peritoneal membrane, facilitating the removal of waste products (urea, creatinine) and excess fluid from the blood into the peritoneal cavity, which is then drained out.
Intraperitoneal administration: 2 L (or appropriate volume based on body size) infused over 10-20 minutes, dwell time 4-6 hours, then drain; typically 4 exchanges per 24 hours.
Intraperitoneal: 2-2.5 L per exchange, 4 exchanges per day (continuous ambulatory peritoneal dialysis).
None Documented
None Documented
Not applicable; dextrose is rapidly metabolized with a half-life of minutes; peritoneal dialysis dwell time is typically 4-6 hours.
Not applicable; dextrose utilization is capacity-limited with half-life of ~1.5 hours in normal circulation. In peritoneal dialysis, the osmotic effect declines over dwell time (2-4 hours) as dextrose is absorbed.
Renal: 100% (dextrose is fully metabolized; water and electrolytes are removed via peritoneal dialysis, not excreted unchanged).
Dextrose is completely metabolized via glycolysis and the citric acid cycle to carbon dioxide and water; <1% excreted unchanged in urine. Osmotic agent effect terminated by peritoneal absorption and systemic metabolism.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution